Gray-market peptides cost more than the vial price, PEPTI analysis argues
Once third-party testing, bacteriostatic water, syringes and wasted vials are added, the discount narrows or disappears.
PR
By Priya Raman · Science Reporter
Sep 11 10:30 ETSource: PEPTI
The wire
- 01PEPTI's monthly-math post itemizes what a research-chemical buyer pays beyond the listed vial price and compares it with a prescribed protocol.
- 02The comparison lands as social platforms and news outlets report a surge in unprescribed peptide use.
- 03The post does not claim any peptide works better from one source; it argues only that the all-in cost gap is smaller than advertised.
From the source
Read at hellopepti.comGray Market Peptides Cost: The Real Monthly Math — PEPTI Blog
Gray market peptides cost more than the vial price once testing, dosing help, and risk are included—see the real math before you buy.
